Laura Joszt

Editorial Director for @AJMC_Journal at @MJHLifeSciences

[Michael Chernew @Michael_Chernew]

It’s awards night in Nashville. Congrats to @IshaniG on winning the 2022 @AJMC_Journal Seema Sonnad Emerging Leader in Managed Care Research Award

[Laura Joszt @joszt]

Alzheimer Disease Drug Lecanemab Successfully Reduces Cognitive, Functional Decline https://t.co/zKtFQBEvku via @AJMC_Journal

[Laura Joszt @joszt]

FDA Advisory Committee Gives Positive Vote for Microbiota-based C. Diff Therapy https://t.co/sdopevbiYn via @denise_myshko

[Laura Joszt @joszt]

Nearly all emergency physicians are seeing an increase in violence, and they say it’s taking a toll on doctors, nurses and patient care. https://t.co/ccSmSsWwPd via @ChiefHealthExec @RonSouthwick1

[Laura Joszt @joszt]

Childhood Trauma Not a Barrier to Successful Depression Treatment, Analysis Finds https://t.co/oGxUUpv9ay via @AJMC_Journal

[Laura Joszt @joszt]

AI Brings New Opportunities for Patient Financial Navigation https://t.co/X6vmeqsy4C via @MHExecutive

[Laura Joszt @joszt]

Report: Generic Drug Spending Rose Due to Formulary Placement https://t.co/nigDgLZsiF via @denise_myshko

[Laura Joszt @joszt]

The Importance of Tailored Care Management Programs for High-risk Patients https://t.co/eVDvZOPdBJ via @AJMC_Journal

[Laura Joszt @joszt]

From Amazon to Zocdoc, health industry urges passage of telemedicine bill https://t.co/k0HawVb1Jo via @ChiefHealthExec @RonSouthwick1

[Laura Joszt @joszt]

In recognizing the value-based aspects that drive patient outcomes within oncology, effective cancer care has been redefined in New Jersey to incorporate cost and health equity at the forefront of innovation https://t.co/ukFZ19BRjW via @AJMC_Journal

[Laura Joszt @joszt]

Panelists at DIA #Biosimilars22 addressed how biosimilars can help address health care disparities and why patient notification for switching to biosimilars must be handled with caution. https://t.co/M9CkYCry3m

[Laura Joszt @joszt]

HIV Care and the Trans Community | A Brief Conversation With Theodore Gideonse, PhD https://t.co/q0yUAKxXtf via @MHExecutive

[Laura Joszt @joszt]

Hospitals have faced increased pressure to reduce their environmental impact, and a new congressional report offers more perspective on what some health systems are doing. https://t.co/wBXSPNWHR9 via @ChiefHealthExec @RonSouthwick1

[Laura Joszt @joszt]

World Health Organization said there is a lack of evidence of clinical effectiveness of the monoclonal antibodies Xevudy and Regen-Cov against the COVID-19 variants that are currently circulating. https://t.co/IY0ZfULJFI via @denise_myshko

[Laura Joszt @joszt]

The FDA issued an alert to users related to a potential cybersecurity risk for Medtronic MiniMed 600 Series Insulin Pump Systems. The risk could allow unauthorized users to change insulin levels https://t.co/FcYjXJSg9U via @Drug_Topics

[Laura Joszt @joszt]

To stem overdoses, Canada is offering safer opioids. Advocates want the U.S. to do the same https://t.co/PlrDQUwko8 via @statnews

[Laura Joszt @joszt]

Prescribing Controlled Substances Goes Electronic https://t.co/NGCLOajCQd via @Pharmacy_Times

[Laura Joszt @joszt]

Part 3 of a @BiosimCenter series dives into how providers, administrators, nurses, and pharmacists can prepare for adalimumab biosimilars and what role they can play in patient acceptance and use of biosimilars https://t.co/F0mSms3OYy

[Laura Joszt @joszt]

Reaching the goals of the Cancer Moonshot 2.0 will require going beyond the traditional measures of success and truly learning from patients and caregivers living with cancer, explained the Moonshot coordinator at the #NCCNPolicy Summit
https://t.co/ydZR2OODPz via @AJMC_Journal

[Laura Joszt @joszt]

‘Patients deserve better’: Hospital leaders describe cuts due to financial crunch https://t.co/c8whTL3E1Y via @ChiefHealthExec @RonSouthwick1